With these improvements, PCNA-based SERS is expected to enable a wider range of biomedical applications such as quantitative analysis of chemical bonds in proteins, accurate evaluation of glucose in blood for diabetes detection, and trace detection of toxic substances in food and water. The gene discussed is PCNA; the disease is diabetes mellitus.